Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mila Poelhekken

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical, Cosmetic and Investigational Dermatology|May 12, 2026
Dermatologists' Perspectives on Skincare Routine TrendsMila Poelhekken, Sebastiaan A S van der Bent
JAAD International|March 7, 2022
The positive impact of rituximab on the quality of life and mental health in patients with pemphigusHanan Rashid, Mila Poelhekken, Joost M Meijer, et al.
Dermatology (Basel, Switzerland)|April 14, 2026
Practitioner-reported complications in tattoo removalMila Poelhekken, Peter J Velthuis, Esther P M Tjin, et al.
International Journal of Dermatology|May 14, 2022
Dupilumab in a child with severe atopic dermatitis and severe asthma-a rare case with severe limbitis and exercise-induced anaphylaxisMila Poelhekken, Fieke M Rosenberg, Jantje M Oldhoff, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 24, 2022
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registryEsmé Kamphuis, Celeste M Boesjes, Laura Loman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical, Cosmetic and Investigational Dermatology|May 12, 2026
Dermatologists' Perspectives on Skincare Routine TrendsMila Poelhekken, Sebastiaan A S van der Bent
JAAD International|March 7, 2022
The positive impact of rituximab on the quality of life and mental health in patients with pemphigusHanan Rashid, Mila Poelhekken, Joost M Meijer, et al.
Dermatology (Basel, Switzerland)|April 14, 2026
Practitioner-reported complications in tattoo removalMila Poelhekken, Peter J Velthuis, Esther P M Tjin, et al.
International Journal of Dermatology|May 14, 2022
Dupilumab in a child with severe atopic dermatitis and severe asthma-a rare case with severe limbitis and exercise-induced anaphylaxisMila Poelhekken, Fieke M Rosenberg, Jantje M Oldhoff, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|December 24, 2022
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registryEsmé Kamphuis, Celeste M Boesjes, Laura Loman, et al.
Pageof 1